Literature DB >> 21862871

Structural and mechanistic commonalities of amyloid-β and the prion protein.

Bianca Da Costa Dias1, Katarina Jovanovic, Danielle Gonsalves, Stefan F T Weiss.   

Abstract

Amyloid β (Aβ) is a major causative agent of Alzheime disease. This neurotoxic peptide is generated as a result of the cleavage of the Amyloid-Precursor-Protein (APP) by the action of beta secretase and gamma secretase. The neurotoxicity was previously thought to be the result of aggregation. However, recent studies suggest that the interaction of Aβ with numerous cell surface receptors such as N-methyl-D-aspartate (NMDA), receptor for advanced glycosylation end products (RAGE), P75 neurotrophin receptor (P75NTR) as well as cell surface proteins such as the cellular prion protein (PrP(c) ) and heparan sulfate proteoglycans (HSPG) strongly enhances Aβ induced apoptosis and thereby contributes to neurotoxicity. This review focuses on the molecular mechanism resulting in Aβ-shedding as well as Aβ-induced apoptotic processes, genetic risk factors for familial Alzheimer disease and interactions of Aβ with cell surface receptors and proteins, with particular emphasis on the cellular prion protein. Furthermore, comparisons are drawn between Alzheimer disease and prion disorders and the role of laminin, an extracellular matrix protein, glycosaminoglycans and the 37 kDa/67 kDa laminin receptor (LRP/LR) have been highlighted with regards to both neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21862871      PMCID: PMC3226036          DOI: 10.4161/pri.5.3.17025

Source DB:  PubMed          Journal:  Prion        ISSN: 1933-6896            Impact factor:   3.931


  113 in total

1.  PRNP Val129 homozygosity increases risk for early-onset Alzheimer's disease.

Authors:  Bart Dermaut; Esther A Croes; Rosa Rademakers; Marleen Van den Broeck; Marc Cruts; Albert Hofman; Cornelia M van Duijn; Christine Van Broeckhoven
Journal:  Ann Neurol       Date:  2003-03       Impact factor: 10.422

2.  Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase.

Authors:  Masashi Asai; Chinatsu Hattori; Beáta Szabó; Noboru Sasagawa; Kei Maruyama; Sei-ichi Tanuma; Shoichi Ishiura
Journal:  Biochem Biophys Res Commun       Date:  2003-01-31       Impact factor: 3.575

Review 3.  Patented biological approaches for the therapeutic modulation of the 37 kDa/67 kDa laminin receptor.

Authors:  Aadilah Omar; Katarina Jovanovic; Bianca Da Costa Dias; Danielle Gonsalves; Kiashanee Moodley; Robert Caveney; Vusi Mbazima; Stefan F T Weiss
Journal:  Expert Opin Ther Pat       Date:  2010-11-27       Impact factor: 6.674

Review 4.  Biochemical and biophysical features of both oligomer/fibril and cell membrane in amyloid cytotoxicity.

Authors:  Massimo Stefani
Journal:  FEBS J       Date:  2010-11       Impact factor: 5.542

Review 5.  Tau in Alzheimer disease and related tauopathies.

Authors:  K Iqbal; F Liu; C-X Gong; I Grundke-Iqbal
Journal:  Curr Alzheimer Res       Date:  2010-12       Impact factor: 3.498

Review 6.  The metallobiology of Alzheimer's disease.

Authors:  Ashley I Bush
Journal:  Trends Neurosci       Date:  2003-04       Impact factor: 13.837

Review 7.  Alzheimer's dementia begins as a disease of small blood vessels, damaged by oxidative-induced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy.

Authors:  Vincent T Marchesi
Journal:  FASEB J       Date:  2011-01       Impact factor: 5.191

8.  Decreased clearance of CNS beta-amyloid in Alzheimer's disease.

Authors:  Kwasi G Mawuenyega; Wendy Sigurdson; Vitaliy Ovod; Ling Munsell; Tom Kasten; John C Morris; Kevin E Yarasheski; Randall J Bateman
Journal:  Science       Date:  2010-12-09       Impact factor: 47.728

Review 9.  Apoptosis and melanoma: molecular mechanisms.

Authors:  Mahmoud R Hussein; Anna K Haemel; Gary S Wood
Journal:  J Pathol       Date:  2003-03       Impact factor: 7.996

Review 10.  The CD95(APO-1/Fas) DISC and beyond.

Authors:  M E Peter; P H Krammer
Journal:  Cell Death Differ       Date:  2003-01       Impact factor: 15.828

View more
  11 in total

Review 1.  Looking into laminin receptor: critical discussion regarding the non-integrin 37/67-kDa laminin receptor/RPSA protein.

Authors:  Vincent DiGiacomo; Daniel Meruelo
Journal:  Biol Rev Camb Philos Soc       Date:  2015-01-28

2.  Global Alzheimer Research Summit: basic and clinical research: present and future Alzheimer research.

Authors:  Danielle Gonsalves; Katarina Jovanovic; Bianca Da Costa Dias; Stefan F T Weiss
Journal:  Prion       Date:  2012 Jan-Mar       Impact factor: 3.931

3.  β-Cleavage of the prion protein in the human eye: Implications for the spread of infectious prions and human ocular disorders.

Authors:  Suman Chaudhary; Ajay Ashok; Aaron S Wise; Neil A Rana; Alexander E Kritikos; Ewald Lindner; Neena Singh
Journal:  Exp Eye Res       Date:  2021-10-07       Impact factor: 3.467

4.  Modulation of γ-secretase activity by multiple enzyme-substrate interactions: implications in pathogenesis of Alzheimer's disease.

Authors:  Zeljko M Svedružić; Katarina Popović; Ivana Smoljan; Vesna Sendula-Jengić
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

5.  Anti-LRP/LR specific antibodies and shRNAs impede amyloid beta shedding in Alzheimer's disease.

Authors:  Katarina Jovanovic; Danielle Gonsalves; Bianca Da Costa Dias; Kiashanee Moodley; Uwe Reusch; Stefan Knackmuss; Clement Penny; Marc S Weinberg; Melvyn Little; Stefan F T Weiss
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

6.  Anti-LRP/LR specific antibody IgG1-iS18 and knock-down of LRP/LR by shRNAs rescue cells from Aβ42 induced cytotoxicity.

Authors:  Bianca Da Costa Dias; Katarina Jovanovic; Danielle Gonsalves; Kiashanee Moodley; Uwe Reusch; Stefan Knackmuss; Clement Penny; Marc S Weinberg; Melvyn Little; Stefan F T Weiss
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

7.  The 37kDa/67kDa laminin receptor acts as a receptor for Aβ42 internalization.

Authors:  Bianca Da Costa Dias; Katarina Jovanovic; Danielle Gonsalves; Kiashanee Moodley; Uwe Reusch; Stefan Knackmuss; Marc S Weinberg; Melvyn Little; Stefan F T Weiss
Journal:  Sci Rep       Date:  2014-07-03       Impact factor: 4.379

Review 8.  Amyloid-beta Alzheimer targets - protein processing, lipid rafts, and amyloid-beta pores.

Authors:  Sage C Arbor; Mike LaFontaine; Medhane Cumbay
Journal:  Yale J Biol Med       Date:  2016-03-24

9.  LRP/LR specific antibody IgG1-iS18 impedes neurodegeneration in Alzheimer's disease mice.

Authors:  Eloise Ferreira; Monique J Bignoux; Tyrone C Otgaar; Nicolas Tagliatti; Katarina Jovanovic; Boitelo T Letsolo; Stefan F T Weiss
Journal:  Oncotarget       Date:  2018-06-05

10.  Activation of Mitochondrial Unfolded Protein Response in SHSY5Y Expressing APP Cells and APP/PS1 Mice.

Authors:  Yang Shen; Mao Ding; Zhaohong Xie; Xiangtian Liu; Hui Yang; Suqin Jin; Shunliang Xu; Zhengyu Zhu; Yun Wang; Dewei Wang; Linlin Xu; Xiaoyan Zhou; Ping Wang; Jianzhong Bi
Journal:  Front Cell Neurosci       Date:  2020-01-08       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.